HopeStage
Back to all studies
SuspendedNCT05394545

Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

Device studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Schaumburg and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: March 20, 2024
Recruitment status
Suspended
Enrollment listed in the registry
80
Sponsor
Nu-Life Solutions
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05394545
Official title
Show the full official title

A Randomized, Phase II, Open-Label Study Evaluating the Nu-V3 Cranial Nerve Stimulation Treatment Device in Patients With Chronic Pain, Anxiety, Depression, and/or Sleeplessness

Recruitment & locations

Suspended

Schaumburg · Greenwood

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nu-Life Solutions.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies